NCT03701490View on ClinicalTrials.gov

Prolutex in Frozen Embryo Transfer Cycles At the Blastocyst Stage (PROGEX)

PHASE2CompletedINTERVENTIONAL
Enrollment

213

Participants

Timeline

Start Date

March 12, 2019

Primary Completion Date

September 28, 2022

Study Completion Date

December 3, 2022

Conditions
Infertility
Interventions
DRUG

Progesterone subcutaneous

25 mg/twice a day.

DRUG

Progesterone Vaginal Product

200 mg three times a day.

Trial Locations (3)

28001

Instituto Bernabeu Madrid, Madrid

41010

Ginemed, Seville

03016

Instituto Bernabeu, Alicante

Sponsors
All Listed Sponsors
lead

IBSA Institut Biochimique SA

INDUSTRY

NCT03701490 - Prolutex in Frozen Embryo Transfer Cycles At the Blastocyst Stage (PROGEX) | Biotech Hunter | Biotech Hunter